Co-Pay Relief Program Announces Assistance for a New Disease Area
… Program eases cost burden for patients with pancreatic cancer
PAF’s Co-Pay Relief (CPR) program is pleased to announce that assistance will now be available to patients with pancreatic cancer through the launch of a new disease fund that can provide direct payment for co-payments, co-insurance and deductibles required by the patient’s insurer for medications prescribed to treat and manage their disease.
Specific information relative to the pancreatic cancer fund is provided below:
Maximum annual award level: $8,000
- Patient must be covered by Medicare, Medicaid, or Military Benefits, and insurance must cover the medication for which patient seeks assistance.
- Patient must have a confirmed diagnosis of pancreatic cancer.
- Patient must reside and receive treatment in the United States.
- Patient’s income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.
The Co-Pay Relief Program may help with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition. The program helps patients on a first-come, first-serve basis and processes applicants in the order in which their completed applications are received.
To apply for assistance please visit https://copays.org/portal/#/login, with access available for patients, providers and pharmacies, or connect with our team via phone at 866-512-3861.